activity
20172026
most citedAutonomous discovery in the chemical sciences part I: Progress

330 citations · 2.7k across the 74 of their papers we have counts for

collaborators
Showing q-bio.QMShow all

21 papers · 1 filter

q-bio.QM2026

Generative structural elucidation from mass spectra as an iterative optimization problem

Mrunali Manjrekar, Runzhong Wang, Samuel Goldman +2

Liquid chromatography tandem mass spectrometry (LC-MS/MS) is a critical analytical technique for molecular identification across metabolomics, environmental chemistry, and chemical…

q-bio.QM2025

Optimal compound downselection to promote diversity and parallel chemistry

Jenna C. Fromer, Alexandra D. Volkova, Connor W. Coley

Early stage drug discovery and molecular design projects often follow iterative design-make-test cycles. The selection of which compounds to synthesize from all possible candidate…

q-bio.QM2023★ 3 cited

An algorithmic framework for synthetic cost-aware decision making in molecular design

Jenna C. Fromer, Connor W. Coley

Small molecules exhibiting desirable property profiles are often discovered through an iterative process of designing, synthesizing, and testing sets of molecules. The selection of…

q-bio.QM2023

Pareto Optimization to Accelerate Multi-Objective Virtual Screening

Jenna C. Fromer, David E. Graff, Connor W. Coley

The discovery of therapeutic molecules is fundamentally a multi-objective optimization problem. One formulation of the problem is to identify molecules that simultaneously exhibit…

q-bio.QM2023★ 25 cited

MIST-CF: Chemical formula inference from tandem mass spectra

Samuel Goldman, Jiayi Xin, Joules Provenzano +1

Chemical formula annotation for tandem mass spectrometry (MS/MS) data is the first step toward structurally elucidating unknown metabolites. While great strides have been made towa…

q-bio.QM2023

Evaluating the roughness of structure-property relationships using pretrained molecular representations

David E. Graff, Edward O. Pyzer-Knapp, Kirk E. Jordan +2

Quantitative structure-property relationships (QSPRs) aid in understanding molecular properties as a function of molecular structure. When the correlation between structure and pro…

q-bio.QM2023★ 2 cited

Generating Molecular Fragmentation Graphs with Autoregressive Neural Networks

Samuel Goldman, Janet Li, Connor W. Coley

The accurate prediction of tandem mass spectra from molecular structures has the potential to unlock new metabolomic discoveries by augmenting the community's libraries of experime…

q-bio.QM2023★ 14 cited

Prefix-Tree Decoding for Predicting Mass Spectra from Molecules

Samuel Goldman, John Bradshaw, Jiayi Xin +1

Computational predictions of mass spectra from molecules have enabled the discovery of clinically relevant metabolites. However, such predictive tools are still limited as they occ…

q-bio.QM2022★ 28 cited

Reinforced Genetic Algorithm for Structure-based Drug Design

Tianfan Fu, Wenhao Gao, Connor W. Coley +1

Structure-based drug design (SBDD) aims to discover drug candidates by finding molecules (ligands) that bind tightly to a disease-related protein (targets), which is the primary ap…

q-bio.QM2022★ 16 cited

De novo PROTAC design using graph-based deep generative models

Divya Nori, Connor W. Coley, Rocío Mercado

PROteolysis TArgeting Chimeras (PROTACs) are an emerging therapeutic modality for degrading a protein of interest (POI) by marking it for degradation by the proteasome. Recent deve…

q-bio.QM2022★ 136 cited

Computer-Aided Multi-Objective Optimization in Small Molecule Discovery

Jenna C. Fromer, Connor W. Coley

Molecular discovery is a multi-objective optimization problem that requires identifying a molecule or set of molecules that balance multiple, often competing, properties. Multi-obj…

q-bio.QM2022★ 49 cited

Roughness of molecular property landscapes and its impact on modellability

Matteo Aldeghi, David E. Graff, Nathan Frey +4

In molecular discovery and drug design, structure-property relationships and activity landscapes are often qualitatively or quantitatively analyzed to guide the navigation of chemi…

q-bio.QM2022★ 6 cited

Self-focusing virtual screening with active design space pruning

David E. Graff, Matteo Aldeghi, Joseph A. Morrone +3

High-throughput virtual screening is an indispensable technique utilized in the discovery of small molecules. In cases where the library of molecules is exceedingly large, the cost…

q-bio.QM2021★ 6 cited

pyscreener: A Python Wrapper for Computational Docking Software

David E. Graff, Connor W. Coley

pyscreener is a Python library that seeks to alleviate the challenges of large-scale structure-based design using computational docking. It provides a simple and uniform interface…

q-bio.QM2021

Machine learning on DNA-encoded library count data using an uncertainty-aware probabilistic loss function

Katherine S. Lim, Andrew G. Reidenbach, Bruce K. Hua +4

DNA-encoded library (DEL) screening and quantitative structure-activity relationship (QSAR) modeling are two techniques used in drug discovery to find small molecules that bind a p…

q-bio.QM2021★ 2 cited

BioNavi-NP: Biosynthesis Navigator for Natural Products

Shuangjia Zheng, Tao Zeng, Chengtao Li +4

Nature, a synthetic master, creates more than 300,000 natural products (NPs) which are the major constituents of FDA-proved drugs owing to the vast chemical space of NPs. To date,…

q-bio.QM2020★ 325 cited

Accelerating high-throughput virtual screening through molecular pool-based active learning

David E. Graff, Eugene I. Shakhnovich, Connor W. Coley

Structure-based virtual screening is an important tool in early stage drug discovery that scores the interactions between a target protein and candidate ligands. As virtual librari…

q-bio.QM2020★ 16 cited

Message Passing Networks for Molecules with Tetrahedral Chirality

Lagnajit Pattanaik, Octavian-Eugen Ganea, Ian Coley +3

Molecules with identical graph connectivity can exhibit different physical and biological properties if they exhibit stereochemistry-a spatial structural characteristic. However, m…

q-bio.QM2020★ 283 cited

Autonomous discovery in the chemical sciences part II: Outlook

Connor W. Coley, Natalie S. Eyke, Klavs F. Jensen

This two-part review examines how automation has contributed to different aspects of discovery in the chemical sciences. In this second part, we reflect on a selection of exemplary…

q-bio.QM2020★ 330 cited

Autonomous discovery in the chemical sciences part I: Progress

Connor W. Coley, Natalie S. Eyke, Klavs F. Jensen

This two-part review examines how automation has contributed to different aspects of discovery in the chemical sciences. In this first part, we describe a classification for discov…

q-bio.QM2020★ 8 cited

The Synthesizability of Molecules Proposed by Generative Models

Wenhao Gao, Connor W. Coley

The discovery of functional molecules is an expensive and time-consuming process, exemplified by the rising costs of small molecule therapeutic discovery. One class of techniques o…